CHINA TOPIX

Updated 2:12 PM EST, Wed, Jan 29, 2020

Make CT Your Homepage

‘Female Viagra’ Gets Advisory Committee Nod, Still Needs Final FDA Approval for Market Release

Viagra

(Photo : Reuters) Touted as the "female Viagra," an advisory committee to the FDA has recommended the drug for approval. Final approval, however, rests with the FDA. Flibanserin is intended to increase the level of sexual drive of women who suffer from Hypoactive Sexual Desire Disorder.

The Flibanserin drug, touted as the "female Viagra," has received a nod from the advisory committee, but it is up to the Food and Drug Administration (FDA) to decide if it will be released.

The majority of the 24-member advisory committee voted in favor of the Flibanserin drug with conditions, Business Insider reported.

Like Us on Facebook

Sprout Pharmaceuticals is the developer of the so-called female Viagra.  According to them, Flibanserin is intended to increase the level of sexual drive of women who suffer from Hypoactive Sexual Desire Disorder, according to the Washington Post.

Although it has been approved by the committee with certain conditions, it is up to the FDA to grant final approval before the drug can be sold to consumers.  The committee also advised that the drug should have the necessary warning clearly labeled and that the women who will take it must be properly educated about its side effects and not only the purported benefits.

This is not the first time that Flibanserin has been submitted to the FDA. In fact, the agency disapproved the drug twice because of its numerous side effects.  It is reported that women who used the drug may get dizzy, faint, or get nauseous, as well as experience problems with sleeping or low blood pressure.

Sprout Pharmaceuticals revealed that their clinical tests improved the number of times that women were sexually satisfied using the drug. Data from a six-month treatment trial period conducted by the company showed that around 46 to 60 percent of its female patients improved their sexual drive.  However, some members in the advisory committee place the figure at around ten percent after considering the number of women who take the placebo pills also improved their sexual drives.

Unlike the Viagra for male, Flibanserin does not concentrate on the female sex organ.  Instead, it manipulates certain transmitters in a woman's brains.  CNN reports that calling this drug a female Viagra is simply not true because it works more like an anti-depressant.  To be effective, women must take the drug regularly before feeling its effect.   

Real Time Analytics